Search Within

Margaret Kathleen Callahan

Formats
  1. Journal Article (105)
  2. Meeting Abstract (84)
  3. Editorial (4)
  4. Book Section (2)
  5. Research Letter (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Department of Medicine (199)
  2. Melanoma and Immunotherapeutics Service (199)
  3. Solid Tumor Oncology Division (199)
  4. GSK Faculty (123)
  5. Melanoma Disease Management Team (108)
  6. Hematologic Malignancies, Division of (77)

More Groups

People
  1. Jedd Wolchok (113)
  2. Michael Postow (96)
  3. Paul Chapman (50)
  4. Alexander Shoushtari (46)
  5. Katherine Panageas (38)
  6. Parisa Momtaz (30)

More People

Years
  1. 2025 (5)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (13)
  5. 2021 (11)
  6. 2020 (19)

More Years

Publications
  1. Journal of Clinical Oncology (61)
  2. Journal for ImmunoTherapy of Cancer (17)
  3. Science Translational Medicine (10)
  4. Annals of Oncology (7)
  5. Clinical Cancer Research (7)
  6. New England Journal of Medicine (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (65)
  2. Biomed Central Ltd (17)
  3. American Association for Cancer Research (15)
  4. Elsevier Inc. (15)
  5. Oxford University Press (15)
  6. Nature Publishing Group (11)

More Publishers

Results (199)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
    Journal Article

    Callahan, M.; Amin, A.; Kaye, F. J.; Morse, M. A.; Taylor, M. H.; Peltola, K. J.; Sharma, P.; O'Reilly, E. M.; Meadows Shropshire, S.; O'Brien, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma
    Journal Article

    Vanguri, R. S.; Smithy, J. W.; Li, Y.; Zhuang, M.; Maher, C. A.; Aleynick, N.; Peng, X.; Al-Ahmadie, H.; Funt, S. A.; Rosenberg, J. E.; more...
    Journal of Pathology (2023)

    Fulltext@MSK | Save
  • A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy
    Journal Article

    Peng, X.; Lee, J.; Adamow, M.; Maher, C.; Postow, M. A.; Callahan, M. K.; Panageas, K. S.; Shen, R.
    Cell Reports Methods (2023)

    Fulltext@MSK | Save
  • Melanomas lacking HLA class I expression and response to checkpoint inhibitor
    Meeting Abstract

    Chapman, P. B.; Jayaprakasam, V. S.; Callahan, M. K.; Shoushtari, A. N.; Postow, M. A.; Lezcano, C.; Wolchok, J. D.; Nandakumar, S.; Chatila, W. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Early ctDNA reduction may identify patients with stable disease and long OS on tebentafusp
    Meeting Abstract

    Feng, D.; Collins, L.; Callahan, M. K.; Sullivan, R. J.; Piperno-Neumann, S.; Nathan, P. D.; Hassel, J. C.; Goodall, H.; Holland, C.; Ranade, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib
    Meeting Abstract

    Chapman, P. B.; Klang, M.; Postow, M. A.; Shoushtari, A. N.; Sullivan, R. J.; Wolchok, J. D.; Wong, P.; Callahan, M. K.; Zippin, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Nivolumab and relatlimab in patients with advanced melanoma that had progressed on anti-programmed death-1/programmed death ligand 1 therapy: Results from the phase I/IIa RELATIVITY-020 trial
    Journal Article

    Ascierto, P. A.; Lipson, E. J.; Dummer, R.; Larkin, J.; Long, G. V.; Sanborn, R. E.; Chiarion-Sileni, V.; DreĢno, B.; Dalle, S.; Schadendorf, D.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save